Preliminary study on IL28B polymorphisms and the effect of immunoprophylaxis for maternal-infant transmission of hepatitis B virus infection

Tian-jiao YANG,Hui YU,Hua-qing ZHONG,Jin MIAO,Qi-rong ZHU
DOI: https://doi.org/10.3969/j.issn.1673-5501.2014.02.007
2014-01-01
Abstract:Objective To investigate whether IL28B polymorphisms are associated with the effect of immunoprophylaxis for maternal-infant transmission of hepatitis B virus infection. Methods Three groups of children were involved in this research,they were immunoprophylaxis success,immunoprophylaxis failure and control groups. A total of 109 children whose mothers were positive for HBsAg / HBeAg received three doses of hepatitis B vaccine( at 0,1 and 6 months of age) alone,or combined with HBIG( within 12 hours after birth and in 2 weeks of age); among which,65 cases were identified as immunoprophylaxis success for they had positive serum HBsAb after vaccination,44 cases were immunoprophylaxis failure for they failed to develop detectable serum HBsAb and had positive HBsAg after vaccination. The control group including 221 healthy children whose mothers were negative for both serum HBsAg and HBeAg also received three doses of hepatitis B vaccine( at 0,1 and 6 months of age) and had positive serum HBsAb after vaccination. Genotype analysis was performed among three groups for IL28B rs12979860,rs12980275 and rs8099917. Results No significant differences were observed in genotype frequency distribution among three groups at the polymorphic sites,rs12979860( P = 0. 266) and rs12980275( P = 0. 051). However,considerable differences were observed concerning the distribution of the rs8099917 genotypes among three groups( P = 0. 009),frequencies of TT genotype were higher in immunoprophylaxis success group when compared with immunoprophylaxis failure group( P = 0. 008). The odds ratio for immunoprophylaxis response was 6. 48( OR = 6. 48,95% CI: 1. 27- 32. 0,P = 0. 025) for TT versus TG / GG at rs8099917 after adjustment for age and gender. Conclusion The frequencies of TT genotype of IL28B rs8099917 were higher in immunoprophylaxis success children compared with immunoprophylaxis failure children
What problem does this paper attempt to address?